{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:49:40Z","timestamp":1793857780572,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The need to investigate the pathogenesis and treatment of nonalcoholic fatty liver disease (NAFLD) has led to the development of multiple mouse models. The aim of this study was to validate a fast food diet (FFD) mouse model that is introduced as being close to the human disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Eight to nine weeks old male and female C57BL\/6\u2009J mice were randomly allocated to a FFD group or to a chow diet (CD) group. Every four weeks, mice were weighed, and blood samples were collected for the measurement of glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglycerides (TGs) and total cholesterol. After 25 weeks, mice were sacrificed, and liver tissue was histologically evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>FFD mice gained more weight (<jats:italic>p<\/jats:italic>\u2009=\u20090.049) and presented a higher liver-to-body weight ratio (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) compared to CD mice. FFD group presented with greater steatosis, hepatocellular ballooning and NAFLD activity score (NAS), whereas lobular inflammation and fibrosis were not significantly different compared to CD. When stratified by sex, NAS was different between FFD and CD groups in both male and female mice. Group by time interaction was significant for weight, ALT and cholesterol, but not for glucose, AST and TGs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>FFD mice presented with morphologic and biochemical features of NAFLD and with greater hepatic steatosis, hepatocellular ballooning and NAS, but not lobular inflammation and fibrosis, compared to CD mice. These results only partly validate the FFD mouse model for NAFLD, at least for a 6-month feeding period.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-024-03769-5","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T11:02:09Z","timestamp":1710932529000},"page":"704-716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Partial validation of a six-month high-fat diet and fructose-glucose drink combination as a mouse model of nonalcoholic fatty liver disease"],"prefix":"10.1007","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3177-2129","authenticated-orcid":false,"given":"Evangelia S.","family":"Makri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Xanthopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Mavrommatis Parasidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Makri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros","family":"Pettas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Tsingotjidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Cheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Ballaouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon","family":"Gerou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Goulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"3769_CR1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/apt.17158","volume":"56","author":"L Henry","year":"2022","unstructured":"L. Henry, J. Paik, Z.M. Younossi, Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world. Aliment. Pharmacol. Ther. 56, 942\u2013956 (2022). https:\/\/doi.org\/10.1111\/apt.17158","journal-title":"Aliment. Pharmacol. Ther."},{"key":"3769_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","volume":"52","author":"E Makri","year":"2021","unstructured":"E. Makri, A. Goulas, S.A. Polyzos, Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch. Med. Res. 52, 25\u201337 (2021). https:\/\/doi.org\/10.1016\/j.arcmed.2020.11.010","journal-title":"Arch. Med. Res."},{"key":"3769_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.metabol.2015.12.009","volume":"65","author":"SA Polyzos","year":"2016","unstructured":"S.A. Polyzos, C.S. Mantzoros, Nonalcoholic fatty future disease. Metab. Clin. Exp. 65, 1007\u20131016 (2016). https:\/\/doi.org\/10.1016\/j.metabol.2015.12.009","journal-title":"Metab. Clin. Exp."},{"key":"3769_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.23736\/s0391-1977.16.02563-3","volume":"42","author":"SA Polyzos","year":"2017","unstructured":"S.A. Polyzos, J. Kountouras, C.S. Mantzoros, Adipose tissue, obesity and non-alcoholic fatty liver disease. Minerva Endocrinol. 42, 92\u2013108 (2017). https:\/\/doi.org\/10.23736\/s0391-1977.16.02563-3","journal-title":"Minerva Endocrinol."},{"key":"3769_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"G. Targher, C.D. Byrne, A. Lonardo, G. Zoppini, C. Barbui, Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. J. Hepatol. 65, 589\u2013600 (2016). https:\/\/doi.org\/10.1016\/j.jhep.2016.05.013","journal-title":"J. Hepatol."},{"key":"3769_CR6","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.dsx.2020.09.030","volume":"14","author":"E Makri","year":"2020","unstructured":"E. Makri, M. Kita, A. Goulas, P. Papaioannidou, Z.A. Efstathiadou, F. Adamidou et al. Comparative effectiveness of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on noninvasive indices of hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus. Diabetes Metab. Syndr. 14, 1913\u20131919 (2020). https:\/\/doi.org\/10.1016\/j.dsx.2020.09.030","journal-title":"Diabetes Metab. Syndr."},{"key":"3769_CR7","doi-asserted-by":"publisher","first-page":"174272","DOI":"10.1016\/j.ejphar.2021.174272","volume":"907","author":"ES Makri","year":"2021","unstructured":"E.S. Makri, A. Goulas, S.A. Polyzos, Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease. Eur. J. Pharmacol. 907, 174272 (2021). https:\/\/doi.org\/10.1016\/j.ejphar.2021.174272","journal-title":"Eur. J. Pharmacol"},{"key":"3769_CR8","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/jpm12071166","volume":"12","author":"ES Makri","year":"2022","unstructured":"E.S. Makri, E. Makri, S.A. Polyzos, Combination therapies for nonalcoholic fatty liver disease. J. Personalized Med. 12, 1166 (2022). https:\/\/doi.org\/10.3390\/jpm12071166","journal-title":"J. Personalized Med."},{"key":"3769_CR9","doi-asserted-by":"publisher","first-page":"154203","DOI":"10.1016\/j.metabol.2020.154203","volume":"111S","author":"SA Polyzos","year":"2020","unstructured":"S.A. Polyzos, E.S. Kang, C. Boutari, E.J. Rhee, C.S. Mantzoros, Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis. Metab. Clin. Exp. 111S, 154203 (2020). https:\/\/doi.org\/10.1016\/j.metabol.2020.154203","journal-title":"Metab. Clin. Exp."},{"key":"3769_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/MCG.0b013e31824587e0","volume":"46","author":"SA Polyzos","year":"2012","unstructured":"S.A. Polyzos, J. Kountouras, C. Zavos, G. Deretzi, Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J. Clin. Gastroenterol. 46, 272\u2013284 (2012). https:\/\/doi.org\/10.1097\/MCG.0b013e31824587e0","journal-title":"J. Clin. Gastroenterol."},{"key":"3769_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jhep.2017.10.031","volume":"68","author":"PK Santhekadur","year":"2018","unstructured":"P.K. Santhekadur, D.P. Kumar, A.J. Sanyal, Preclinical models of non-alcoholic fatty liver disease. J. Hepatol. 68, 230\u2013237 (2018). https:\/\/doi.org\/10.1016\/j.jhep.2017.10.031","journal-title":"J. Hepatol."},{"key":"3769_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1152\/physiolgenomics.00179.2010","volume":"43","author":"I Rubio-Aliaga","year":"2011","unstructured":"I. Rubio-Aliaga, B.D. Roos, M. Sailer, G.A. McLoughlin, M.V. Boekschoten, M. van Erk et al. Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention. Physiol. Genomics 43, 408\u2013416 (2011). https:\/\/doi.org\/10.1152\/physiolgenomics.00179.2010","journal-title":"Physiol. Genomics"},{"key":"3769_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88097-8","volume":"11","author":"GJP Rautureau","year":"2021","unstructured":"G.J.P. Rautureau, B. Morio, S. Guibert, C. Lefevre, J. Perrier, A. Alves et al. Dietary obesity in mice is associated with lipid deposition and metabolic shifts in the lungs sharing features with the liver. Sci. Rep. 11, 8712 (2021). https:\/\/doi.org\/10.1038\/s41598-021-88097-8","journal-title":"Sci. Rep."},{"key":"3769_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/path.4829","volume":"241","author":"JK Lau","year":"2017","unstructured":"J.K. Lau, X. Zhang, J. Yu, Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances. J. Pathol. 241, 36\u201344 (2017). https:\/\/doi.org\/10.1002\/path.4829","journal-title":"J. Pathol."},{"key":"3769_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4254\/wjh.v11.i8.619","volume":"11","author":"KT Vel\u00e1zquez","year":"2019","unstructured":"K.T. Vel\u00e1zquez, R.T. Enos, J.E. Bader, A.T. Sougiannis, M.S. Carson, I. Chatzistamou et al. Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice. World J. Hepatol. 11, 619\u2013637 (2019). https:\/\/doi.org\/10.4254\/wjh.v11.i8.619","journal-title":"World J. Hepatol."},{"key":"3769_CR16","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/oby.2005.136","volume":"13","author":"H J\u00fcrgens","year":"2005","unstructured":"H. J\u00fcrgens, W. Haass, T.R. Casta\u00f1eda, A. Sch\u00fcrmann, C. Koebnick, F. Dombrowski et al. Consuming fructose-sweetened beverages increases body adiposity in mice. Obesity research 13, 1146\u20131156 (2005). https:\/\/doi.org\/10.1038\/oby.2005.136","journal-title":"Obesity research"},{"key":"3769_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/hep.23797","volume":"52","author":"R Kohli","year":"2010","unstructured":"R. Kohli, M. Kirby, S.A. Xanthakos, S. Softic, A.E. Feldstein, V. Saxena et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology (Baltimore, Md) 52, 934\u2013944 (2010). https:\/\/doi.org\/10.1002\/hep.23797","journal-title":"Hepatology (Baltimore, Md)"},{"key":"3769_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1152\/ajpgi.00145.2011","volume":"301","author":"M Charlton","year":"2011","unstructured":"M. Charlton, A. Krishnan, K. Viker, S. Sanderson, S. Cazanave, A. McConico et al. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am. J. Physiol. Gastrointestinal Liver Physiol. 301, 825\u2013834 (2011). https:\/\/doi.org\/10.1152\/ajpgi.00145.2011","journal-title":"Am. J. Physiol. Gastrointestinal Liver Physiol."},{"key":"3769_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1152\/ajpgi.00213.2016","volume":"312","author":"A Krishnan","year":"2017","unstructured":"A. Krishnan, T.S. Abdullah, T. Mounajjed, S. Hartono, A. McConico, T. White et al. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition. Am. J. Physiol. Gastrointestinal Liver Physiol. 312, 666 (2017). https:\/\/doi.org\/10.1152\/ajpgi.00213.2016","journal-title":"Am. J. Physiol. Gastrointestinal Liver Physiol."},{"key":"3769_CR20","doi-asserted-by":"publisher","first-page":"G159","DOI":"10.1152\/ajpgi.zh3-6827-corr.2014","volume":"308","author":"M Charlton","year":"2015","unstructured":"M. Charlton, A. Krishnan, K. Viker, S. Sanderson, S. Cazanave, A. McConico et al. Corrigendum in: Fast food diet mouse: novel small animal model of NASH with ballooning, progressivefibrosis, and high physiological fidelity to the human condition. Am. J. Physiol. Gastrointestinal Liver Physiol. 308, G159 (2015). https:\/\/doi.org\/10.1152\/ajpgi.zh3-6827-corr.2014","journal-title":"Am. J. Physiol. Gastrointestinal Liver Physiol."},{"key":"3769_CR21","doi-asserted-by":"publisher","first-page":"3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"N. Percie du Sert, V. Hurst, A. Ahluwalia, S. Alam, M.T. Avey, M. Baker et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 18, 3000410 (2020). https:\/\/doi.org\/10.1371\/journal.pbio.3000410","journal-title":"PLoS Biol."},{"key":"3769_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/0023677217724823","volume":"52","author":"AJ Smith","year":"2018","unstructured":"A.J. Smith, R.E. Clutton, E. Lilley, K.E.A. Hansen, T. Brattelid, PREPARE: guidelines for planning animal research and testing. Lab. Anim. 52, 135\u2013141 (2018). https:\/\/doi.org\/10.1177\/0023677217724823","journal-title":"Lab. Anim."},{"key":"3769_CR23","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, O.W. Cummings et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (Baltimore, Md) 41, 1313\u20131321 (2005). https:\/\/doi.org\/10.1002\/hep.20701","journal-title":"Hepatology (Baltimore, Md)"},{"key":"3769_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s42000-021-00339-6","volume":"21","author":"I Vachliotis","year":"2022","unstructured":"I. Vachliotis, A. Goulas, P. Papaioannidou, S.A. Polyzos, Nonalcoholic fatty liver disease: lifestyle and quality of life. Hormones (Athens, Greece) 21, 41\u201349 (2022). https:\/\/doi.org\/10.1007\/s42000-021-00339-6","journal-title":"Hormones (Athens, Greece)"},{"key":"3769_CR25","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","volume":"68","author":"T Jensen","year":"2018","unstructured":"T. Jensen, M.F. Abdelmalek, S. Sullivan, K.J. Nadeau, M. Green, C. Roncal et al. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J. Hepatol. 68, 1063\u20131075 (2018). https:\/\/doi.org\/10.1016\/j.jhep.2018.01.019","journal-title":"J. Hepatol."},{"key":"3769_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-nutr-062220-025831","volume":"42","author":"S Jung","year":"2022","unstructured":"S. Jung, H. Bae, W.S. Song, C. Jang, Dietary fructose and fructose-induced pathologies. Ann. Rev. Nutr. 42, 45\u201366 (2022). https:\/\/doi.org\/10.1146\/annurev-nutr-062220-025831","journal-title":"Ann. Rev. Nutr."},{"key":"3769_CR27","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1194\/jlr.M900022-JLR200","volume":"50","author":"MK Pickens","year":"2009","unstructured":"M.K. Pickens, J.S. Yan, R.K. Ng, H. Ogata, J.P. Grenert, C. Beysen et al. Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis[S]. J. Lipid Res. 50, 2072\u20132082 (2009). https:\/\/doi.org\/10.1194\/jlr.M900022-JLR200","journal-title":"J. Lipid Res."},{"key":"3769_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.4254\/wjh.v8.i16.673","volume":"8","author":"MN Kristiansen","year":"2016","unstructured":"M.N. Kristiansen, S.S. Veidal, K.T. Rigbolt, K.S. T\u00f8lb\u00f8l, J.D. Roth, J. Jelsing et al. Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy. World J. Hepatol. 8, 673\u2013684 (2016). https:\/\/doi.org\/10.4254\/wjh.v8.i16.673","journal-title":"World J. Hepatol."},{"key":"3769_CR29","doi-asserted-by":"publisher","first-page":"15791","DOI":"10.3390\/ijms232415791","volume":"23","author":"CM Flessa","year":"2022","unstructured":"C.M. Flessa, N. Nasiri-Ansari, I. Kyrou, B.M. Leca, M. Lianou, A. Chatzigeorgiou et al. Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research. Int. J. Mol. Sci. 23, 15791 (2022). https:\/\/doi.org\/10.3390\/ijms232415791","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"3769_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1872-034X.2007.00008.x","volume":"37","author":"M Ito","year":"2007","unstructured":"M. Ito, J. Suzuki, S. Tsujioka, M. Sasaki, A. Gomori, T. Shirakura et al. Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet. Hepatol. Res. 37(1), 50\u201357 (2007). https:\/\/doi.org\/10.1111\/j.1872-034X.2007.00008.x","journal-title":"Hepatol. Res."},{"key":"3769_CR31","doi-asserted-by":"publisher","first-page":"115922","DOI":"10.1371\/journal.pone.0115922","volume":"9","author":"W Liang","year":"2014","unstructured":"W. Liang, A.L. Menke, A. Driessen, G.H. Koek, J.H. Lindeman, R. Stoop et al. Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology. PloS One 9, 115922 (2014). https:\/\/doi.org\/10.1371\/journal.pone.0115922","journal-title":"PloS One"},{"key":"3769_CR32","doi-asserted-by":"publisher","first-page":"bio041251","DOI":"10.1242\/bio.041251","volume":"8","author":"N Abe","year":"2019","unstructured":"N. Abe, S. Kato, T. Tsuchida, K. Sugimoto, R. Saito, L. Verschuren et al. Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients. Biology Open 8, bio041251 (2019). https:\/\/doi.org\/10.1242\/bio.041251","journal-title":"Biology Open"},{"key":"3769_CR33","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1194\/jlr.M072454","volume":"58","author":"GN Ioannou","year":"2017","unstructured":"G.N. Ioannou, S. Subramanian, A. Chait, W.G. Haigh, M.M. Yeh, G.C. Farrell et al. Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH. J. Lipid Res. 58, 1067\u20131079 (2017). https:\/\/doi.org\/10.1194\/jlr.M072454","journal-title":"J. Lipid Res."},{"key":"3769_CR34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","volume":"65","author":"A Asgharpour","year":"2016","unstructured":"A. Asgharpour, S.C. Cazanave, T. Pacana, M. Seneshaw, R. Vincent, B.A. Banini et al. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. J. Hepatol. 65, 579\u2013588 (2016). https:\/\/doi.org\/10.1016\/j.jhep.2016.05.005","journal-title":"J. Hepatol."},{"key":"3769_CR35","doi-asserted-by":"publisher","unstructured":"Fei, N., Miyoshi, S., Hermanson, J.B., Miyoshi, J., Xie, B., DeLeon, O., et al. (2023) Imbalanced gut microbiota predicts and drives the progression of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in a fast-food diet mouse model. bioRxiv : the preprint server for biology https:\/\/doi.org\/10.1101\/2023.01.09.523249.","DOI":"10.1101\/2023.01.09.523249"},{"key":"3769_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-017-0680-z","volume":"17","author":"TH Kim","year":"2017","unstructured":"T.H. Kim, D. Choi, J.Y. Kim, J.H. Lee, S.-H. Koo, Fast food diet-induced non-alcoholic fatty liver disease exerts early protective effect against acetaminophen intoxication in mice. BMC Gastroenterol. 17, 124 (2017). https:\/\/doi.org\/10.1186\/s12876-017-0680-z","journal-title":"BMC Gastroenterol."},{"key":"3769_CR37","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1152\/ajpgi.90272.2008","volume":"295","author":"LH Tetri","year":"2008","unstructured":"L.H. Tetri, M. Basaranoglu, E.M. Brunt, L.M. Yerian, B.A. Neuschwander-Tetri, Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am. J. Physiol. Gastrointestinal Liver Physiol. 295, 987\u2013995 (2008). https:\/\/doi.org\/10.1152\/ajpgi.90272.2008","journal-title":"Am. J. Physiol. Gastrointestinal Liver Physiol."},{"key":"3769_CR38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/jhep.2002.30692","volume":"35","author":"S Chitturi","year":"2002","unstructured":"S. Chitturi, S. Abeygunasekera, G.C. Farrell, J. Holmes-Walker, J.M. Hui, C. Fung et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology (Baltimore, Md) 35, 373\u2013379 (2002). https:\/\/doi.org\/10.1053\/jhep.2002.30692","journal-title":"Hepatology (Baltimore, Md)"},{"key":"3769_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jhep.2012.02.023","volume":"57","author":"SE Keating","year":"2012","unstructured":"S.E. Keating, D.A. Hackett, J. George, N.A. Johnson, Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J. Hepatol. 57, 157\u2013166 (2012). https:\/\/doi.org\/10.1016\/j.jhep.2012.02.023","journal-title":"J. Hepatol."},{"key":"3769_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/iep.12008","volume":"94","author":"M Matsumoto","year":"2013","unstructured":"M. Matsumoto, N. Hada, Y. Sakamaki, A. Uno, T. Shiga, C. Tanaka et al. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int. J. Exp. Pathol. 94, 93\u2013103 (2013). https:\/\/doi.org\/10.1111\/iep.12008","journal-title":"Int. J. Exp. Pathol."},{"key":"3769_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/ejcn.2011.223","volume":"66","author":"M Maersk","year":"2012","unstructured":"M. Maersk, A. Belza, J.J. Holst, M. Fenger-Gr\u00f8n, S.B. Pedersen, A. Astrup et al. Satiety scores and satiety hormone response after sucrose-sweetened soft drink compared with isocaloric semi-skimmed milk and with non-caloric soft drink: a controlled trial. Eur. J. Clin. Nutr. 66, 523\u2013529 (2012). https:\/\/doi.org\/10.1038\/ejcn.2011.223","journal-title":"Eur. J. Clin. Nutr."},{"key":"3769_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnut.2015.00005","volume":"2","author":"K Lowette","year":"2015","unstructured":"K. Lowette, L. Roosen, J. Tack, P. Vanden Berghe, Effects of high-fructose diets on central appetite signaling and cognitive function. Front. Nutr. 2, 5 (2015). https:\/\/doi.org\/10.3389\/fnut.2015.00005","journal-title":"Front. Nutr."},{"key":"3769_CR43","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"K. Riazi, H. Azhari, J.H. Charette, F.E. Underwood, J.A. King, E.E. Afshar et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851\u2013861 (2022). https:\/\/doi.org\/10.1016\/s2468-1253(22)00165-0","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"3769_CR44","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.26761","volume":"59","author":"JD Yang","year":"2014","unstructured":"J.D. Yang, M.F. Abdelmalek, H. Pang, C.D. Guy, A.D. Smith, A.M. Diehl et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology (Baltimore, Md) 59, 1406\u20131414 (2014). https:\/\/doi.org\/10.1002\/hep.26761","journal-title":"Hepatology (Baltimore, Md)"},{"key":"3769_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37007-1","volume":"13","author":"SA Mondal","year":"2023","unstructured":"S.A. Mondal, S.N. Mann, C. van der Linden, R. Sathiaseelan, M. Kamal, S. Das et al. Metabolic benefits of 17\u03b1-estradiol in liver are partially mediated by ER\u03b2 in male mice. Sci. Rep. 13, 9841 (2023). https:\/\/doi.org\/10.1038\/s41598-023-37007-1","journal-title":"Sci. Rep."},{"key":"3769_CR46","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jcmgh.2021.05.010","volume":"12","author":"S Ganguly","year":"2021","unstructured":"S. Ganguly, G.A. Muench, L. Shang, S.B. Rosenthal, G. Rahman, R. Wang et al. Nonalcoholic steatohepatitis and HCC in a hyperphagic mouse accelerated by western diet. Cellular Mol. Gastroenterol. Hepatol. 12, 891\u2013920 (2021). https:\/\/doi.org\/10.1016\/j.jcmgh.2021.05.010","journal-title":"Cellular Mol. Gastroenterol. Hepatol."},{"key":"3769_CR47","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/gutjnl-2020-323323","volume":"71","author":"S Smati","year":"2022","unstructured":"S. Smati, A. Polizzi, A. Fougerat, S. Ellero-Simatos, Y. Blum, Y. Lippi et al. Integrative study of diet-induced mouse models of NAFLD identifies PPAR\u03b1 as a sexually dimorphic drug target. Gut 71, 807\u2013821 (2022). https:\/\/doi.org\/10.1136\/gutjnl-2020-323323","journal-title":"Gut"},{"key":"3769_CR48","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/hep.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"M.E. Rinella, J.V. Lazarus, V. Ratziu, S.M. Francque, A.J. Sanyal, F. Kanwal et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology (Baltimore, Md) 78, 1966\u20131986 (2023). https:\/\/doi.org\/10.1097\/hep.0000000000000520","journal-title":"Hepatology (Baltimore, Md)"},{"key":"3769_CR49","doi-asserted-by":"publisher","first-page":"154413","DOI":"10.1016\/j.metabol.2020.154413","volume":"113","author":"SA Polyzos","year":"2020","unstructured":"S.A. Polyzos, E.S. Kang, E.A. Tsochatzis, S. Kechagias, M. Ekstedt, S. Xanthakos et al. Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name. Metab. 113, 154413 (2020). https:\/\/doi.org\/10.1016\/j.metabol.2020.154413","journal-title":"Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03769-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03769-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03769-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T11:55:58Z","timestamp":1722426958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03769-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3769"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03769-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"18 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"S.A.P.: Boehringer Ingelheim (Greece) provided him a research grant through his institution. All other authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal procedures were carried out in accordance with the relevant National and European Union regulations and were approved by the General Directorate of Agriculture, Economy and Veterinary Medicine of the region of Central Macedonia, Greece, which reviewed and approved the study. The study was also approved by the Bioethics Committee, School of Medicine, Aristotle University of Thessaloniki, Greece.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}